SCHEMBL12916729

SCHEMBL12916729

O=C(c1ccc(Cl)cc1)N1CCN([C@H]2CN(c3ccc4cccc(Cl)c4n3)CC2O)CC1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 1/20 0.42
▸ TACR3 P29371 1/20 0.41
▸ SLC6A7 Q99884 1/20 0.40
▸ KMT2A Q03164 2/20 0.39
▸ SLC18A3 Q16572 1/20 0.39
▸ PDE10A Q9Y233 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ MGLL Q99685 4/20 0.39
▸ MAPT P10636 2/20 0.39
▸ HPGD P15428 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ LMNA P02545 1/20 0.38
▸ AKR1C3 P42330 1/20 0.38
▸ GBA1 P04062 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1257932 1.00 HSD17B10 (0.42) HSD17B10TACR3SLC6A7KMT2ASLC18A3
SCHEMBL6372754 1.00 HSD17B10 (0.42) HSD17B10TACR3SLC6A7KMT2ASLC18A3
SCHEMBL1257910 0.86 SMN1; SMN2 (0.55) HSD17B10SLC6A7SLC18A3PDE10AALDH1A1
SCHEMBL6372084 0.86 SMN1; SMN2 (0.55) HSD17B10SLC6A7SLC18A3PDE10AALDH1A1
SCHEMBL1258711 0.86 SLC6A7 (0.40) HSD17B10SLC6A7KMT2ASLC18A3ALDH1A1
SCHEMBL6373463 0.86 SLC6A7 (0.40) HSD17B10SLC6A7KMT2ASLC18A3ALDH1A1
SCHEMBL6371864 0.83 GBA1 (0.46) HSD17B10SLC6A7KMT2ASLC18A3ALDH1A1
SCHEMBL6373344 0.82 HRH3 (0.49) HSD17B10SLC6A7KMT2APDE10AALDH1A1
SCHEMBL1258218 0.82 HRH3 (0.49) HSD17B10SLC6A7KMT2APDE10AALDH1A1
SCHEMBL6468876 0.81 MGLL (0.42) HSD17B10TACR3SLC6A7SLC18A3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7880002-B2 Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-02-01 — — US disclosed
Send feedback